Figure 1From: A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy Conventional treatment plane with IrisTM collimator: 35 Gy delivered to the 80% isodose line, tumor coverage 99%, and conformality index 1.22. Back to article page